Join the Oncology Voice Network. Join for Free
"You Cannot Teach Someone How to be an MSL"
Medical Science Liaison MSL skills KOL engagement strategies MSL career tips drug launch stages

"You Cannot Teach Someone How to be an MSL"


Share This Article


Summary

In this episode, Kathleen Bailey joins Tom Caravela to explore the essential skills for Medical Science Liaisons (MSLs). They highlight the importance of communication, trust-building, and soft skills, along with strategies for real-time problem-solving and handling objections. Kathleen shares insights on managing unknown questions, the value of mentorship, and drug launch stages. She also offers tips for mastering scientific knowledge, staying updated, and the role of motivation in an MSL career. The episode wraps up with effective KOL engagement strategies and key takeaways.

Kathleen Bailey, Medical Science Liaison at Scynexis discusses what aspects can be taught to MSLs and what needs to be learned through experience.

Kathleen shares…

πŸ‘‰ What aspects of the MSL role can be taught

πŸ‘‰ What aspects of the MSL role cannot be taught and need to be learned

πŸ‘‰ Best practices for bridging the gap

πŸ‘‰ Advice on how to find success and improve performance

Click for Source
Medical Science Liaison, MSL skills, KOL engagement strategies, MSL career tips, drug launch stages

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN